{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:20:43Z","timestamp":1787239243139,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.4158\/ep-2018-0157","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T12:09:45Z","timestamp":1536149385000},"page":"756-763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Familial Chylomicronemia Syndrome: A Clinical Guide for Endocrinologists"],"prefix":"10.1016","volume":"24","author":[{"given":"James M.","family":"Falko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2018-0157_bb0010","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline","volume":"97","author":"Berglund","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0157_bb0015","series-title":"Endotext [Internet]","article-title":"Risk Assessment and Guidelines for the Management of High Triglycerides","author":"Tannock","year":"2000"},{"key":"10.4158\/EP-2018-0157_bb0020","series-title":"The Metabolic and Molecular Basis of Inherited Disease","article-title":"Familial lipoprotein lipase deficiency and hepatic lipase deficiency","author":"Brunzell","year":"2001"},{"key":"10.4158\/EP-2018-0157_bb0025","series-title":"GeneReviews(R)","article-title":"Familial lipoprotein lipase deficiency","author":"Burnett","year":"1993"},{"key":"10.4158\/EP-2018-0157_bb0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","article-title":"Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia","volume":"272","author":"Surendran","year":"2012","journal-title":"J Intern Med"},{"key":"10.4158\/EP-2018-0157_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2015.04.815","article-title":"Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia","volume":"241","author":"Rabacchi","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.4158\/EP-2018-0157_bb0040","first-page":"249","article-title":"Chylomicronemia syndrome","volume":"37","author":"Chait","year":"1992","journal-title":"Adv Intern Med"},{"key":"10.4158\/EP-2018-0157_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17512433.2017.1251839","article-title":"Building a better understanding of the burden of disease in familial chylomicronemia syndrome","volume":"10","author":"Ahmad","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.4158\/EP-2018-0157_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.10702","article-title":"Diagnosis and Management of Type I and Type V Hyperlipoproteinemia","volume":"19","author":"Gotoda","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"10.4158\/EP-2018-0157_bb0055","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/ajg.2015.261","article-title":"Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis","volume":"110","author":"Nawaz","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.4158\/EP-2018-0157_bb0060","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jacl.2016.03.048","article-title":"Acute pancreatitis is highly prevalent and complications can be fatal in patients with familial chylomicronemia: results from a survey of lipidologist","volume":"10","author":"Gaudet","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.4158\/EP-2018-0157_bb0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/14779072.2017.1311786","article-title":"The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study","volume":"15","author":"Davidson","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.4158\/EP-2018-0157_bb0070","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/14779072.2017.1372193","article-title":"The burden of familial chylomicronemia syndrome from the patients' perspective","volume":"15","author":"Gelrud","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.4158\/EP-2018-0157_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.epsc.2016.12.001","article-title":"The fatty spleen: severe hypertriglyceridemia leading to splenomegaly in a child","volume":"17","author":"Kniery","year":"2017","journal-title":"J Pediatr Surg Case Rep"},{"key":"10.4158\/EP-2018-0157_bb0080","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0140-6736(02)11202-5","article-title":"Siblings with hepatosplenomegaly and lipoprotein lipase deficiency","volume":"360","author":"Schneider","year":"2002","journal-title":"Lancet"},{"key":"10.4158\/EP-2018-0157_bb0085","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/ajg.2013.218","article-title":"American College of Gastroenterology guideline: management of acute pancreatitis","volume":"108","author":"Tenner","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.4158\/EP-2018-0157_bb0090","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00383-014-3595-6","article-title":"Predictors for mortality following acute pancreatitis in children","volume":"30","author":"Guo","year":"2014","journal-title":"Pediatr Surg Int"},{"key":"10.4158\/EP-2018-0157_bb0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02803766","article-title":"Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats","volume":"20","author":"Kimura","year":"1996","journal-title":"Int J Pancreatol"},{"key":"10.4158\/EP-2018-0157_bb0100","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ejim.2014.08.008","article-title":"Current knowledge of hypertriglyceridemic pancreatitis","volume":"25","author":"Valdivielso","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.4158\/EP-2018-0157_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(14)60649-8","article-title":"Acute pancreatitis","volume":"386","author":"Lankisch","year":"2015","journal-title":"Lancet"},{"key":"10.4158\/EP-2018-0157_bb0110","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/MPA.0b013e318221f569","article-title":"Progression from acute to chronic pancreatitis: prognostic factors, mortality, and natural course","volume":"40","author":"N\u00f8jgaard","year":"2011","journal-title":"Pancreas"},{"key":"10.4158\/EP-2018-0157_bb0115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","article-title":"Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer","volume":"1","author":"Hart","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.4158\/EP-2018-0157_bb0120","article-title":"Severe hypertriglyceridemia induced pancreatitis in pregnancy","volume":"2014","author":"Gupta","year":"2014","journal-title":"Case Rep Obstet Gynecol"},{"key":"10.4158\/EP-2018-0157_bb0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0899-9007(97)85060-5","article-title":"Treatment of severe familial hypertriglyceridemia during pregnancy with very-low-fat diet and n-3 fatty acids","volume":"12","author":"Glueck","year":"1996","journal-title":"Nutrition"},{"key":"10.4158\/EP-2018-0157_bb0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.pan.2016.02.011","article-title":"Systemic review of hypertriglyride induced pancreatitis-a more virulent etiology","volume":"16","author":"Carr","year":"2016","journal-title":"Pancreatology"},{"key":"10.4158\/EP-2018-0157_bb0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1471-0528.1992.tb14481.x","article-title":"Management of patients with severe hypertriglyceridaemia during pregnancy: report of two cases with familial lipoprotein lipase deficiency","volume":"99","author":"Watts","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"10.4158\/EP-2018-0157_bb0140","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jacl.2015.12.015","article-title":"Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency","volume":"10","author":"Rodrigues","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.4158\/EP-2018-0157_bb0145","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2014current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.4158\/EP-2018-0157_bb0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacl.2010.11.004","article-title":"Etiology and risk of lactescent plasma and severe hypertriglyceridemia","volume":"5","author":"Tremblay","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.4158\/EP-2018-0157_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2016.10.002","article-title":"Diagnostic algorithm for familial chylomicronemia syndrome","volume":"23","author":"Stroes","year":"2017","journal-title":"Atheroscler Suppl"},{"key":"10.4158\/EP-2018-0157_bb0160","series-title":"GeneReviews\u2122 [Internet]","article-title":"Familial lipoprotein lipase deficiency","author":"Brunzell","year":"1993"},{"key":"10.4158\/EP-2018-0157_bb0165","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.atherosclerosis.2017.06.059","article-title":"The approach study: a randomized, double-blind, placebo-controlled, phase 3 study of volanesorsen administered subcutaneously to patients with familial chylomicronemia syndrome (FCS)","volume":"263","author":"Gaudet","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.4158\/EP-2018-0157_bb0170","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.atherosclerosissup.2017.08.003","article-title":"Apolipoprotein C-III inhibition with volanesorsen in patients with hypertriglyceridemia (COMPASS): a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Gouni-Berthold","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.4158\/EP-2018-0157_bb0175","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"10.4158\/EP-2018-0157_bb0180","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.4158\/EP-2018-0157_bb0185","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5551\/jat.11.286","article-title":"Apolipoprotein B as a marker of familial hyperlipoproteinemia","volume":"11","author":"Sveger","year":"2004","journal-title":"J Atheroscler Thromb"},{"key":"10.4158\/EP-2018-0157_bb0190","doi-asserted-by":"crossref","first-page":"e99721","DOI":"10.1371\/journal.pone.0096482","article-title":"Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects","volume":"9","author":"Di Filippo","year":"2014","journal-title":"PLoS One"},{"key":"10.4158\/EP-2018-0157_bb0195","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet","year":"2014","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2018-0157_bb0200","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.urology.2004.06.040","article-title":"Adherence to a low-fat diet in men with prostate cancer","volume":"64","author":"Link","year":"2004","journal-title":"Urology"},{"key":"10.4158\/EP-2018-0157_bb0205","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacl.2014.08.010","article-title":"Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1","volume":"8","author":"Ahmad","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.4158\/EP-2018-0157_bb0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/humc.2013.087","article-title":"Lessons learned from the clinical development and market authorization of Glybera","volume":"24","author":"Bryant","year":"2013","journal-title":"Hum Gene Ther Clin Dev"},{"key":"10.4158\/EP-2018-0157_bb0215","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMcp070061","article-title":"Clinical practice. Hypertriglyceridemia","volume":"357","author":"Brunzell","year":"2007","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2018-0157_bb0220","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jca.20232","article-title":"Plasmapheresis in the treatment of hypertriglyceridemia-induced pancreatitis: A community hospital's experience","volume":"25","author":"Syed","year":"2010","journal-title":"J Clin Apher"},{"key":"10.4158\/EP-2018-0157_bb0225","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.3748\/wjg.v19.i42.7276","article-title":"Diagnosis and treatment of diabetes mellitus in chronic pancreatitis","volume":"19","author":"Ewald","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.4158\/EP-2018-0157_bb0230","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/2013.jamainternmed.477","article-title":"Hypertriglyceridemia and acute pancreatitis","volume":"173","author":"Murphy","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.4158\/EP-2018-0157_bb0235","article-title":"A systematic review of the epidemiology, pathophysiology and current management of hyperlipidaemic pancreatitis","author":"Adiamah","year":"2017","journal-title":"Clin Nutr"},{"key":"10.4158\/EP-2018-0157_bb0240","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1517\/21678707.2015.1078728","article-title":"Complexities in transitioning a child with a rare disorder","volume":"3","author":"Morales","year":"2015","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.4158\/EP-2018-0157_bb0245","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jacl.2017.11.002","article-title":"Reduced psychological distress in familial chylomicronemia syndrome after patient support group intervention","volume":"12","author":"Wilson","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.4158\/EP-2018-0157_bb0250","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1089\/hum.2015.158","article-title":"Long term restrospective analysis of gene therapy with alipogene tiparvovec and its effect of lipoprotein lipase defeciency induced pancreatitis","volume":"27","author":"Gaudet","year":"2016","journal-title":"Hum Gene Ther"},{"key":"10.4158\/EP-2018-0157_bb0255","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/jamainternmed.2013.13309","article-title":"Severe hypertriglceridemia with pancreatitis: thirteen years' treatment with lomitapide","volume":"174","author":"Sacks","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.4158\/EP-2018-0157_bb0260","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/21678707.2018.1419863","article-title":"Advances in diagnosis and potential therapeutic options for familial chylomicronemia syndrome","volume":"6","author":"Benes","year":"2018","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.4158\/EP-2018-0157_bb0265","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1400283","article-title":"Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia","volume":"373","author":"Gaudet","year":"2015","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2018-0157_bb0270","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/dc16-0126","article-title":"Antisense-mediated lowering of plasma apolipoprotein C-III by volanesorsen improves dyslipidemia and insulin sensitivity in type 2 diabetes","volume":"39","author":"Digenio","year":"2016","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2018-0157_bb0275","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/14712598.2016.1196182","article-title":"Anti-sense oligonucleotide therapies for the treatment of hyperlipidaemia","volume":"16","author":"Wierzbicki","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"10.4158\/EP-2018-0157_bb0280","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJMc1705994","article-title":"ANGPTL3 inhibition in homozygous familial hypercholesterolemia","volume":"377","author":"Gaudet","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20354227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20354227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:04:44Z","timestamp":1761516284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20354227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1530891X20354227"],"URL":"https:\/\/doi.org\/10.4158\/ep-2018-0157","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial Chylomicronemia Syndrome: A Clinical Guide for Endocrinologists","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2018-0157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}